Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38)
Clinical trial NCT01045161 · COMPLETED
Trial details
- NCT number
- NCT01045161
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2011-06-01
- Enrollment
- 544
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.